secwatch.observer — SEC 8-K summary
======================================

Issuer:     XOMA Royalty Corp (XOMA)
CIK:        0000791908
Form:       8-K
Filed at:   2025-05-13T23:59:59+00:00
Accession:  0001193125-25-118322
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

XOMA Royalty Q1 net income $2.4M, total revenues $15.9M; adds Castle Creek royalty, sells Kinnate assets
--------------------------------------------------------------------------------

- Q1 2025 total revenues $15.9M (vs $1.5M Q1 2024); net income $2.4M (vs net loss $8.6M).
- Cash receipts $18.0M in Q1, including $13.4M royalties and $4.6M milestones; cash $95.0M at March 31.
- Acquired Phase 3 royalty interest in Castle Creek's D-Fi (DEB) for $5M; sold all unpartnered Kinnate assets.
- Milestone: $4.0M from Day One/Ipsen MAA filing for tovorafenib with EMA; $3.0M net from Takeda Phase 3 start (Q2).
- Share repurchases: $0.5M for 25,828 shares; paid $1.4M in preferred dividends.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/791908/000119312525118322/0001193125-25-118322-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/791908/000119312525118322/d905797d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-118322

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer